BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 19, 2016
View Archived Issues
Abzena and Baylor Scott & White Research Institute establish Denceptor Therapeutics joint venture
Read More
Savara closes acquisition of Serendex Pharmaceuticals
Read More
Merck & Co. patents describe BTK inhibitors
Read More
Universidad de Chile patents adeno-associated virus to treat cognitive disorders
Read More
Pierre Fabre Medicament discloses humanized antibodies for cancer therapy
Read More
Novira Therapeutics reports antiviral compounds
Read More
Targeting RANK pathway for breast cancer prevention in BRCA1-mutation carriers
Read More
MabVax starts enrollment in phase I trial of PET-imaging agent
Read More
Beta1-Integrin is a novel therapeutic target in pathological conditions of the muscle
Read More
T2 Biosystems and Bayer enter collaboration for hemostasis drug discovery and development
Read More
Auris Medical obtains fast track designation for Keyzilen
Read More
NEAT1 is a promising new target to modulate replication stress response and chemosensitivity
Read More
Phase II study of NurOwn for ALS meets primary endpoint
Read More
EVK-001 phase III clinical trial does not meet primary endpoint
Read More
ADCY9 gene polymorphisms affect dalcetrapib effects on cardiovascular outcomes
Read More
FDA approves Prezista expanded prescribing information
Read More
Nivolumab marketing applications accepted for filing
Read More
The EMA classifies AXAL as advanced therapy medicinal product
Read More
EMA accepts Ipsen's MAA for telotristat etiprate
Read More
Helix BioPharma and NRC enter agreement in principle to collaborate on immuno-oncology initiatives
Read More
Vernalis and Servier achieve a milestone in oncology collaboration
Read More
Merck & Co. begins enrolling participants in phase I trial of MK-1966 in combination with SD-101
Read More
FDA clears Bexion Pharmaceuticals' phase I application for BXQ-350
Read More
Avedro receives additional indication for Photrexa Viscous, Photrexa and the KXL System
Read More
FDA approves Berinert as the first and only pediatric treatment for hereditary angioedema
Read More
Soligenix to present positive preliminary results of a heat stable Ebola vaccine formulation
Read More